Swiss Re · 1 day ago
Claims & Underwriting Innovation Specialist - Hybrid
Swiss Re is one of the world’s leading providers of reinsurance, insurance and other forms of insurance-based risk transfer. The L&H Claims & UW Innovation Specialist will enhance workflows, champion digital tool utilization, and support innovative initiatives to strengthen underwriting and claims operations.
CRMInformation TechnologyInsuranceRisk ManagementWholesale
Responsibilities
Lead improvement initiatives to identify, recommend, and implement efficiency enhancements across mortality services workflows to optimize turnaround time, quality, and process consistency
Champion digital adoption of tools such as UCM, Claims Manager, and reporting platforms, including support for training, communication, and implementation activities
Represent business needs during the development, testing, and rollout of system enhancements and new technology solutions
Bridge communication between business stakeholders and technology partners to ensure solutions meet operational requirements
Support the change management activities to facilitate smooth transitions during implementation of new processes and tools
Analyze workflows to identify bottlenecks and opportunities for optimization across underwriting and claims operations
Qualification
Required
Business knowledge of underwriting and/or claims processes within U.S. L&H
Experience or interest in innovation, process optimization, or workflow improvement initiatives
Proven ability to collaborate across regions, groups and divisions within an organization
Ability to manage small projects, prioritize effectively, and independently deliver results
Ability to make data-driven decisions
Preferred
Experience with digital tools, reporting platforms, and/or operational technology
Knowledge of MSBI, Excel, or AI-enabled reporting tools
Change management experience
Experience in agile project environments
Company
Swiss Re
Swiss Re Group is a wholesale provider of reinsurance, insurance, and other insurance-based forms of risk transfer.
Funding
Current Stage
Public CompanyTotal Funding
$700MKey Investors
JP Morgan
2023-03-07Post Ipo Debt· $700M
2018-04-04Post Ipo Equity
2011-05-27IPO
Leadership Team
Recent News
2026-01-05
2026-01-03
The Real Deal
2026-01-03
Company data provided by crunchbase